Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors

Bioorganic & Medicinal Chemistry Letters
2018.0

Abstract

A series of readily accessible 4-arylimino-3-hydroxybutanoic acids have been prepared and evaluated as potential HIV-1 Integrase inhibitors. None of the ligands exhibited significant toxicity against human embryonic kidney (HEK 293) cells, while five of them showed activity against HIV-1 integrase - the most active (6c) with an IC50 value of 3.5 μM. In silico docking studies indicate the capacity of ligand 6c to interact with several amino acid residues and the two Mg2+ cations in the HIV-1 integrase receptor cavity.

Knowledge Graph

Similar Paper

Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase
European Journal of Medicinal Chemistry 2015.0
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry 2007.0
4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in Cells
Journal of Medicinal Chemistry 2000.0
Synthesis and evaluation of substituted 4-(N-benzylamino)cinnamate esters as potential anti-cancer agents and HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors
ACS Medicinal Chemistry Letters 2015.0
4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors
ACS Medicinal Chemistry Letters 2013.0
Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs
Bioorganic & Medicinal Chemistry Letters 2014.0
Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity
Bioorganic & Medicinal Chemistry Letters 2012.0